Abstract:Neurodegenerative diseases are characterized by chronic progressive degeneration of the structure and function of the nervous system, which brings an enormous burden on patients, their families, and society. It is difficult to make early diagnosis, resulting from the insidious onset and progressive development of neurodegenerative diseases. The drugs on the market cannot cross the blood–brain barrier (BBB) effectively, which leads to unfavorable prognosis and less effective treatments. Therefore, there is an urgent demand to develop a novel detection method and therapeutic strategies. Recently, nanomedicine has aroused considerable attention for diagnosis and therapy of central nervous system (CNS) diseases. Nanoparticles integrate targeting, imaging, and therapy in one system and facilitate the entry of drug molecules across the blood–brain barrier, offering new hope to patients. In this review, we summarize the application of iron oxide nanoparticles (IONPs) in the diagnosis and treatment of neurodegenerative disease, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). We focus on IONPs as magnetic resonance imaging (MRI) contrast agents (CAs) and drug carriers in AD. What most neurodegenerative diseases have in common is that hall marker lesions are represented by protein aggregates (<a href="#B58">Soto and Pritzkow, 2018</a>). These diseases are of unknown etiology and unfavorable prognosis, and the treatments toward them are less effective (<a href="#B58">Soto and Pritzkow, 2018</a>). Such diseases usually develop in aged people, and early clinical manifestations are atypical, resulting in difficulty in early diagnosis. Recently, nanomedicine has aroused considerable attention for therapy and diagnosis of CNS diseases because it integrates targeting, imaging, and therapy in one system (<a href="#B30">Gupta et al., 2019</a>). In this review article, we first introduce the neurodegenerative diseases and commonly used MRI CAs. Then we review the application of IONPs in the diagnosis and treatment of neurodegenerative diseases with the purpose of assisting early theranostics (therapy and diagnosis).

Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases

Engineering nanoprobes for magnetic resonance imaging of brain diseases

Functional tumor imaging based on inorganic nanomaterials

Bioinorganic Materials for Imaging, Diagnosis and Therapy of Neurological Disease

Advances of Functional Nanomaterials for Magnetic Resonance Imaging and Biomedical Engineering Applications.

Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applications

Inorganic Nanomaterials for Tumor Angiogenesis Imaging

Rare-earth based materials: an effective toolbox for brain imaging, therapy, monitoring and neuromodulation

The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders

Advances of NIR Light Responsive Materials for Diagnosis and Treatment of Brain Diseases

Correction: Rare-earth Based Materials: an Effective Toolbox for Brain Imaging, Therapy, Monitoring and Neuromodulation

Progress of advanced nanomaterials in diagnosis of neurodegenerative diseases

Introduction: Nanomedicine In The Brain

Advances in nanomedicines for diagnosis of central nervous system disorders

Application of Nanomaterials in Neurodegenerative Diseases

Rare-earth Nanomaterials for Potential Brain Disease Theranostics

Nanoparticles-mediated Brain Imaging and Disease Prognosis by Conventional as well as Modern Modal Imaging Techniques: A Comparison

Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease

Nanomaterials in Neural‐Stem‐Cell‐Mediated Regenerative Medicine: Imaging and Treatment of Neurological Diseases

Nanoparticle-Based Activatable MRI Probes for Disease Imaging and Monitoring

Near-Infrared Inorganic Nanomaterials for Precise Diagnosis and Therapy